SciELO - Scientific Electronic Library Online

 
vol.20 issue6Association of PRKAA1 gene polymorphisms with chronic hepatitis B virus infection in Chinese Han populationTargeted preemptive therapy according to perceived risk of CMV infection after kidney transplantation author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Article

Indicators

Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google
  • uBio

Share


Brazilian Journal of Infectious Diseases

Print version ISSN 1413-8670
On-line version ISSN 1678-4391

Braz J Infect Dis vol.20 no.6 Salvador Nov./Dec. 2016

http://dx.doi.org/10.1016/j.bjid.2016.09.004 

Original Articles

Anogenital infection by Chlamydia trachomatis and Neisseria gonorrhoeae in HIV-infected men and women in Salvador, Brazil

Ana Gabriela Travassosa  b  * 

Eveline Xavier-Souzac 

Eduardo Nettoc 

Eda Vinhaes Dantasb 

Maiara Timbóc 

Isabella Nóbregab 

Tatiana Haguiharab 

Júlia Neumayerc 

Nathalia Lisboac 

Maria Angela Soidanb 

Fábio Ferreirad 

Carlos Britesc 

aUniversidade Estadual da Bahia (UNEB), Salvador, BA, Brazil

bCentro Estadual Especializado em Diagnóstico, Assistência e Pesquisa (CEDAP), Salvador, BA, Brazil

cUniversidade Federal da Bahia (UFBA), Salvador, BA, Brazil

dLaboratório Central de Saúde Pública Professor Gonçalo Moniz (LACEN-BA), Salvador, BA, Brazil

ABSTRACT

Background:

Infections caused by Chlamydia trachomatis and Neisseria gonorrhoeae are the most common bacterial sexually transmitted infections throughout the world. These sexually transmitted infections are a growing problem in people living with HIV/AIDS. However, the presence of these agents in extra genital sites, remains poorly studied in our country. The objective of this study was to estimate the prevalence of Chlamydia trachomatis and Neisseria gonorrhoeae anal and genital infection in people living with HIV/AIDS followed in a reference center in Salvador, Brazil.

Methods:

Cross-sectional study, from June 2013 to June 2015. Proven HIV-infected people attending this reference center were invited. Clinical and epidemiological data were obtained through interview with standardized form. Chlamydia trachomatis and Neisseria gonorrhoeae screening was performed using qPCR (COBAS 4800® Roche).

Results:

The frequency of positive cases of Chlamydia trachomatis and Neisseria gonorrhoeae was 12.3% in total, 9.2% cases amongst women and 17.1% amongst men. We found 14.0% of positive cases in anus and 3.1% in genital region in men, while 5.6% and 3.6%, in women, respectively. Among men, anal infection was associated with age <29 years (p = 0.033), report of anal intercourse (p = 0.029), pain during anal intercourse (p = 0.028). On the other hand, no association between genital infection and other variables were detected in bivariate analysis. Among women, we detected an association between Chlamydia trachomatis genital infection and age <29 years (p < 0.001), younger age at first sexual intercourse (p = 0.048), pregnancy (p < 0.001), viral load >50 copies/mL (p = 0.020), and no antiretroviral use (p = 0.008). Anal infection in women was associated with age <29 years old (p < 0.001) and pregnancy (p = 0.023), and was not associated with report of anal intercourse (p = 0.485).

Conclusion:

Missed opportunities for diagnosis in extra genital sites could impact on HIV transmission. The extra genital sites need to be considered to break the HIV and bacterial sexually transmitted infections chain-of-transmission.

Keywords: HIV; Chlamydia trachomatis; Neisseria gonorrhoeae; Sexually transmitted infections; Anogenital infections

Introduction

Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) infections are the most common bacterial sexually transmitted infections (STI) throughout the world.1 These infections may cause complications both in men and women, such as epididymitis, urethritis, cervicitis, pelvic inflammatory disease, and ectopic pregnancy.1,2 STI in extragenital sites, such as anus, rectum, and pharynx, are an increasing cause for concern. Recent studies show increasing reports of anal intercourse amongst heterosexuals and lower rates of condom use in anal intercourse compared to vaginal intercourse.3 Anorectal mucosa is vulnerable to HIV due to lack of appropriate protective humoral immune barrier and for being more susceptible to traumatic lesions then the vaginal mucosa.4 In addition, possible biological, behavioral, and social factors, such as insufficient knowledge regarding anorectal STI risks and anal intercourse to please the partner also contribute to STI infection.5 The low percentage of diagnostic screening in addition to inappropriate treatment maintain the bacterial STI chain-of-transmission, thus increasing STI and HIV transmission.6

The presence of CT and NG infection, especially in the anorectal region, is associated to the increased risk of HIV infection. In people living with HIV/AIDS (PLHA), CT and NG infections increase the genital HIV viral load (VL) and the possibility of sexual and vertical transmission of the virus.7 Despite the raise of the HIV epidemics amongst men who have sex with men (MSM) highlight the role of unprotected anal intercourse on the HIV transmission, the role of this practice in the heterosexual HIV transmission is still poorly understood.

Although studies show anorectal prevalence for CT in women (6.6-9.3%) to be similar to that of MSM (6.5-10.1%) and the therapeutic recommendations for infections on this site possibly differ from those in the urogenital sites,6,8,9 there is still no definition regarding the systematic investigation for CT and NG in extragenital sites in heterosexual women.

The aim of this study was to estimate the prevalence of anorectal and genital infection by C. trachomatis and Neisseria gonorrhea and the associated risk factors, such as lifestyle and sexual practices, in women and men living with HIV/AIDS receiving care in a reference center in Salvador, Brazil.

Material and methods

Patients and settings

This was a cross-sectional study conducted at Centro Especializado em Diagnóstico, Assistência e Pesquisa (CEDAP) from June 2013 to June 2015. CEDAP is the state reference center for STI and HIV in Salvador, Bahia, Northeast of Brazil, attending approximately 60% of PLHA in the state, with an average of 76 new cases of HIV/AIDS and 373 new cases of STI each month. The health center is staffed with infectious disease specialists, and other medical and paramedical professionals. Irrespective of their area of specialization physicians are trained to deliver care for patients with sexually transmitted diseases.

Confirmed HIV-infected patients undergoing treatment with the gynecologist and proctologist at the clinic were invited to participate in the study, regardless of their signs and symptoms of STI. Sexually active patients regardless of age were assessed. Patients who had used antibiotics 30 days before from the appointment, and women with genital bleeding at the exam were not included. Pregnant women with no recent obstetric complications were also included in this study.

Laboratory tests

The CT and NG screening was performed using qPCR in closed system - In vitro Diagnostic (IVD), COBAS 4800® Roche, using COBAS® PCR Media Female as transport for the endocervix and anorectal specimens, and COBAS® PCR Media Urine for male urine samples. The samples were collected according to the manufacturer instructions. The anorectal samples collection was adapted for COBAS® PCR Media Female, as it is not standardized for the IVD from COBAS 4800® Roche system. The anorectal samples were collected through the swab introduced 2-3 cm after anal margin and it was done in 360° turn; endocervix samples were collected by gynecologist during specular exam; and urine was collected by the patients in adequate recipients. The samples were collected during a medical appointment at CEDAP and were processed at the Professor Gonçalo Moniz Central Laboratory of Public Health of Bahia - LACEN-BA.

All patients had a blood sample drawn to assess HIV viral load and TCD4+/TCD8+ cells count at the time of the appointment. Lymphocyte TCD4+/TCD8+ count was performed by flow cytometry (Facscalibur, Becton and Dickinson, California, USA) and HIV viral load was quantified using PCR Real time (Abbot molecular, Illinois, USA)

Data collection

Socio-demographic, behavioral, and clinical data were obtained through standardized medical interview. Patients were scheduled further medical appointment one month after sample collection for delivering tests results and prescribing treatment of the identified infections. All patients signed a written informed consent. This study was approved by the Ethics Committee of the Maternidade Climério de Oliveira/Universidade Federal da Bahia (process 292,413).

Statistical analyses

Data analysis were performed using SPSS 20.0 (SPSS Inc, Chicago, IL, USA). Chi-square test was used for univariate analysis of categorical variables like ethnicity (white × non-white), marital status (single × married/stable union), schooling (≤8 years of study × >8 years of study), alcohol intake, tobacco and drug use (yes × no). Continuous variables such as age, age at first intercourse, number of partners, and time since HIV diagnosis were analyzed by Student's t test. p-values lower than 0.05 were considered statistically significant; 95% confidence intervals (CI) were calculated for means and proportions. Variables with p ≤ 0.20 in univariate analysis were included in the logistic regression backward stepwise model for multivariate analysis. For women, the variables in the regression were: age, schooling, pregnancy, alcohol use, drugs use, pelvic pain, cervicitis, genital discharge, alcohol before sex, anal receptive intercourse, HAART use, HIV viral load. For men, those who referred no anal receptive intercourse were excluded from the logistic regression analysis because they did not have CT or NG anal infection. Therefore, the variables analyzed were: age, ethnicity, alcohol before sex, pain in anal intercourse, genital ulcer and painful anorectal exam.

Results

A total of 521 PLHA, 208 men and 313 women were evaluated. Of those, 15 (2.9%) men who did not collect a urine sample and eight (2.6%) women who had inadequate anorectal samples were excluded. There was no statistically significant difference between the enrolled and excluded patients.

The final sample comprised 305 women and 193 men. The overall prevalence of any CT or NG infection was 12.3% (61/498), 9.2% (28/305) cases amongst women and 17.1% (33/193) amongst men. The overall mean age was 37.0 years (±10.5), 10.4% (52/498) self-reported to be white, 38.6% (192/498) were married or in a common-law marriage, and 73.5% (366/498) had more than eight years of regular education. A total of 83.1% (414/498) were on antiretroviral therapy, but 37.0% (165/446) had viral load above 40 copies/mL.

Some significant differences between genders were found in this study sample. Men were younger, mostly single, with higher education and family income. Alcohol, tobacco and drug use were more frequently declared by men, as well as higher number of sexual partners, receptive anal sex, and history of STI, as seen on Table 1.

Table 1 Clinical and socio-demographic characteristics of 498 people living with HIV/AIDS, in Salvador, Brazil, according to gender. 

Characteristics Men (n = 193) Women (n = 305) p-Value
Age (years), mean (SD) 35.8 (9.9) 37.7 (10.8) 0.042
Age at sexual debut (years), mean (SD) 14.9 (3.4) 16.4 (3.5) <0.001
Lifetime number of sexual partners, median (IQR) 30 (12–200) 5 (3–10) <0.001
White race, n (%) 30 (15.5) 22 (7.2) 0.003
Married/cohabitating
Marital status, n (%)
46 (23.8) 159 (52.1) <0.001
Educational level ≥8 years, n (%) 170 (88.1) 196 (64.3) <0.001
Monthly household income ≤2 minimum wages, n (%)a 102 (53.4) 252 (82.6) <0.001
Alcohol use, n (%) 144 (74.6) 166 (54.4) <0.001
Tobacco use, n (%) 42 (21.9) 29 (9.6) <0.001
Drug use, n (%) 52 (26.9) 43 (14.1) <0.001
Alcohol use before sex, n (%) 91 (47.2) 123 (40.9) 0.169
Drug use before sex, n (%) 32 (16.6) 23 (7.5) 0.002
Transactional sex, n (%) 19 (9.8) 28 (9.2) 0.805
Anal receptive intercourse, n (%) 167 (86.5) 191 (62.6) <0.001
Previous STI, n (%) 167 (86.5) 151 (49.5) <0.001
Time from HIV diagnosis (months, median (IQR) 42.5 (10.5–121.7) 85.2 (32.8–136.8) <0.001
ART in use, n (%) 159 (82.4) 255 (83.6) 0.722
Duration on ART (days), median (IQR) 24.3 (2.0–82.6) 48.7 (3.0–121.7) 0.004

STI, sexually transmitted infections.The numbers do not always add up the total because of missing values.

aMinimum wage ≈$194.

Amongst women, there were seven cases of combined CT infection (endocervix and anus). Two men (6.1%) had both anorectal and urine positive for NG infection, and one (3.0%) for CT infection in both sites. Regarding the investigated site, there were 14.0% (27/193) of positive cases in anus and 3.1% (6/193) in genital region in men, while 5.6% (17/305) and 3.6% (11/305) cases in women, respectively (Table 2).

Table 2 Prevalence of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) in 498 people living with HIV/AIDS, in Salvador, Brazil. 

Chlamydia trachomatis
n/N (%)
Neisseria gonorrhoeae
n/N (%)
Totala
n/N (%)
Male
Anus 18/193 (9.3) 11/193 (5.7) 27/193 (14.0)
Urine 3/193 (1.6) 3/193 (1.6) 6/193 (3.1)
Female
Anus 16/305 (5.3) 2/305 (0.7) 17/305 (5.6)
Endocervix 11/305 (3.6) 0/305 (0.0) 11/305 (3.6)

aExcluded co-infections.

Clinical, behavioral, and epidemiological aspects associated with the presence of CT and NG infection in genital and anorectal areas in men and women are described in Table 3. Among men, anorectal infection was associated with age <29 years (p = 0.033), report of anal intercourse (p = 0.029), pain during anal intercourse (p = 0.028), and painful anorectal exam (p = 0.022). Only men who referred anal intercourse have CT and NG anal infection. After logistic regression, the variables that remained significantly associated with anorectal infection were painful anorectal exam (p = 0.014, OR-3.59, 95% CI 1.29-9.95), and white ethnicity (p = 0.018, OR-3.85, 95% CI 1.26-11.77). On the other hand, no association between genital infection and other variables were detected in univariate analysis. After logistic regression, only lifetime sexual partners >3 (p = 0.019, OR-22.41, 95% CI 1.67-305.94) was independently associated with genital infection.

Table 3 Univariate analysis of sociodemographic, clinical and sexual behavior-related risk factors for Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) infection in 498 people living with HIV, in Salvador, Brazil. 

Men Women
Urogenital CT/NG (n = 6) Anorectal CT/NG ( n = 27) Endocervical CT/NG ( n = 11) Anorectal CT/NG ( n = 17)
n (%) p OR 95% CI n (%) p OR 95% CI n (%) p OR 95% CI n (%) p OR 95% CI
Socio-demographic
Age ≤29 years old 2 (3.8) .669 1.32 0.24–7.45 12 (22.6) .023 2.61 1.12–6.10 8 (10.8) .001 9.21 2.38–35.71 11 (14.9) .000 6.55 6.33–18.40
Single 4 (2.7) .652 0.62 0.12–3.31 21 (14.3) .832 1.11 0.42–2.95 5 (3.1) .630 0.76 0.23–2.54 11 (6.9) .285 1.73 0.63–4.82
White ethnicity 2 (6.7) .235 2.84 0.50–16.25 7 (23.3) .108 2.18 0.82–5.72 1 (4.5) .567 1.30 0.16–10.65 3 (13.6) .114 3.03 0.80–11.48
Less than 8 schooling years 0 (0.0) 1.000 1.04 1.01–1.07 2 (8.7) .748 0.55 0.12–2.50 8 (7.3) .020 5.10 1.32–19.63 7 (6.4) .630 1.27 0.47–3.46
Monthly income ≤2 MWa 3 (2.9) 1.000 0.87 0.17–4.42 15 (14.7) .809 1.11 0.49–2.51 11 (4.4) .222 0.96 0.93–0.98 14 (5.6) 1.000 0.98 0.27–3.54
Pregnant women 6 (18.8) .000 12.37 3.53–43.31 5 (15.6) .023 4.03 1.32–12.30
Alcohol use 5 (3.5) 1.000 1.73 0.20–15.15 22 (15.3) .376 1.59 0.57–4.45 3 (1.8) .120 0.30 0.08–1.16 8 (4.8) .530 0.73 0.27–1.95
Tobacco use 2 (4.8) .614 1.83 0.32–10.33 6 (14.3) .962 1.02 0.39–2.73 0 (0.0) .608 1.04 1.02–1.07 1 (3.4) 1.000 0.58 0.07–4.51
Drug use 2 (3.8) .661 1.37 0.24–7.71 9 (17.3) .420 1.43 0.60–3.42 3 (7.0) .191 2.38 0.60–9.35 1 (2.3) .483 0.37 0.05–2.83
Sex-risk behaviors
Lifetime sexual partners >3 2 (66.6) .092 18.20 1.41–235.34 2 (66.6) .370 3.10 0.27–35-38 6 (3.0) .409 1.66 0.50–5.57 9 (4.5) .237 1.80 0.67–4.80
Irregular condom use 2 (4.8) .614 1.83 0.32–10.32 7 (16.7) .583 1.30 0.51–3.32 3 (3.0) 1.000 0.75 0.19–2.88 3 (3.0) .194 0.41 0.12–1.47
Alcohol before sex 3 (3.3) 1.000 1.13 0.22–5.72 17 (18.7) .076 2.11 0.91–4.89 1 (0.8) .031 0.14 0.02–1.09 6 (4.9) .631 0.78 0.28–2.16
Drug before sex 1 (3.1) 1.000 1.01 0.11–8.92 4 (12.5) 1.000 0.86 0.28–2.67 1 (4.3) .584 1.24 0.15–10.11 1 (4.3) 1.000 0.76 0.10–5.97
Transactional sex 0 (0.0) 1.000 1.04 1.01–1.07 2 (10.5) 1.000 0.70 0.15–3.22 2 (7.2) .267 2.29 0.47–11.17 1 (3.6) 1.000 0.60 0.08–4.73
Anal receptive intercourse 5 (3.0) .585 0.77 0.09–6.88 27 (16.2) .029 0.84 0.78–0.90 4 (2.1) .108 0.33 0.09–1.14 12 (6.3) .485 1.46 0.50–4.26
Previous STI 6 (3.6) 1.000 0.96 0.94–0.99 26 (15.6) .136 4.61 0.60–35.53 6 (4.0) .734 1.23 0.39–4.13 6 (4.0) .228 0.54 0.19–1.49
Patient complaints
Anal fissureb 2 (3.4) 1.000 1.12 0.20–6.31 10 (16.9) .456 1.38 0.59–3.23
Pain in anal intercourse 2 (4.0) .676 1.28 0.23–7.23 12 (24.0) .028 2.55 1.09–5.99
Dyspareunia 3 (4.5) .706 1.36 0.33–5.62 5 (7.6) .696 1.24 0.42–3.73
Genital discharge 1 (16.7) .178 7.12 0.70–72.72 1 (16.7) .594 1.26 0.14–11.27 6 (5.5) .188 2.21 0.66–7.43 9 (8.3) .131 2.10 0.79–5.62
Genital ulcer 1 (4.0) .570 1.36 0.15–12.13 6 (24.0) .122 2.21 0.79–6.16 0 (0.0) 1.000 1.04 1.02–1.06 0 (0.0) .610 1.06 1.03–1.09
Pelvic pain 0 (0.0) 1.000 0.58 0.07–4.66 3 (17.6) .713 1.35 0.36–5.04 6 (5.5) .188 0.58 0.18–1.85 4 (3.7) .313 0.53 0.17–1.68
Anal pain 2 (2.6) 1.000 0.74 0.13–4.14 14 (18.2) .179 1.74 0.77–3.95 0 (0.0) 1.000 1.04 1.02–1.07 0 (0.0) .614 1.06 1.03–1.09
Clinical findings
Anal fissureb 1 (1.6) .666 0.38 0.04–3.36 9 (14.1) .914 1.05 0.44–2.51
Genital discharge 1 (20.0) .148 9.15 0.86–97.35 1 (20.0) .533 1.56 0.17–14.49 5 (4.7) .463 1.57 0.47–5.26 6 (5.6) .985 1.01 0.36–2.81
Urethritis 1 (16.7) .175 7.28 0.71–74.35 1 (16.7) 1.000 1.24 0.14–11.03
Cervicitis 3 (13.6) .037 5.43 1.33–22.14 3 (13.6) .114 3.03 0.80–11.48
Painful anorectal examb 0 (0.0) .585 1.04 1.00–1.07 9 (25.0) .022 2.88 1.13–7.34
Painful bimanual exam 2 (7.7) .270 2.28 0.47–11.15 0 (0.0) .382 1.07 1.04–1.11
Viral load .650 2.52 0.27–23.03 .626 0.79 0.31–2.01 .020 0.20 0.05–0.78 .051 0.36 0.12–1.04
≤40 cp/mL 4 (4.0) 12 (11.9) 3 (1.7) 6 (3.3)
>40 cp/mL 1 (1.6) 9 (14.5) 8 (7.8) 9 (7.8)
CD4+ ≤500 cells/µL 1 (1.7) .653 0.42 0.05–3.84 10 (16.7) .271 1.67 0.66–4.21 3 (3.6) 1.000 0.92 0.24–3.55 7 (8.4) .178 1.99 0.72–5.55
No ART in use 1 (2.94) 1.000 1.07 0.12–9.48 5 (14.7) .894 0.93 0.33–2.66 5 (10.0) .008 0.22 0.06–0.74 5 (10.0) .136 0.44 0.15–1.32

CT/NG indicates chlamydia and/or gonorrhea infection.

aMW, minimum wage ≈$194.

bInvestigation on anal fissure and painful anorectal exam were only performed by the proctologist in male patients.

Among women, there was an association between CT genital infection and age less than 29 years old (p < 0.001), younger age at first sexual intercourse (p = 0.048), schooling less than eight years (p = 0.020), pregnancy (p < 0.001), viral load >50 copies/mL (p = 0.020), and no antiretroviral use (p = 0.008). After logistic regression, age less than 29 years old (p = 0.010, OR-8.25, 95% CI 1.67-40.76), schooling less than eight years (p = 0.012, OR-8.29, 95% CI 1.61-42.77), pregnancy (p = 0.002, OR-13.57, 95% CI 2.63-69.94), alcohol use before sexual act (p = 0.025, OR-14.54, 95% CI 1.39-151.61), and cervicitis (p = 0.056, OR-6.18, 95% CI 0.96-39.97) remained statistically significant.

Anorectal infection in women was associated with age less than 29 years old (p < 0.001) and pregnancy (p = 0.023), but it was neither associated with report of anal intercourse (p = 0.485) nor presence of symptoms. Only age less than 29 years old (p = 0.001, OR-10.54, 95% CI 3.23-34.41) remained associated with infection after logistic regression.

Discussion

A high prevalence of CT and NG infection in PLHA (12.3%) was found in this study, which was higher among men (17.7%) than women (9.2%). Infections were more prevalent in the anorectal (8.8%) site than in the genital (3.8%) site. Nowadays, there is an increase in anorectal STI, even among heterosexuals.3,9,10 Some guidelines recommend CT and NG screening in extragenital sites on MSM, however it remains undefined for heterosexuals.11,12 Some authors suggest focusing the screening on women who report anal intercourse.10,13 The lack of association between women reporting anal intercourse and presence of anorectal infection in our study corroborate the findings of a study conducted in Baltimore, 2014.14 The presence of bacterial infection with or without symptoms in anus and rectum, the practice of anal intercourse in the general population, and the increasing risk of HIV transmission reinforce the need for appropriate STI diagnosis and treatment on anorectal site. In this study, if the screening had been only urogenital, CT and NG infection diagnoses would have been missed in 88.9% of cases in men and 58.8% in women.

Amongst the women evaluated on this study, the association between anorectal and genital site of infection and younger age (p < 0.001 on both cases) and pregnancy (p < 0.001 and p = 0.023) highlights the need for screening that population during routine follow-up. These associations have been found in studies with women living with HIV/AIDS, and in the general population,15-17 but it is not yet a routine in most services in Latin America. Recent studies detected a higher chance of HIV vertical transmission on women co-infected with NG or CT.18,19 A systematic CT and NG investigation for young women, pregnant women, and women living with HIV/AIDS can contribute to the reduction of HIV transmission, and be an effective prevention measure.

In our study, the prevalence found on women's anorectal region was 5.3% for CT and 0.7% for NG; 29.4% of women with infection in the anorectal region denied practice of anal intercourse. There are few reports regarding the investigation of this site in women who do not admit anal intercourse or symptoms on the anal region.10 The prevalence rates described in women with this practice vary between 8.6%-12.7% for CT and 1.0%-2.9% for NG on anorectal sites.6,14,20 We found an association between presence of infection in cervix and in anorectal site, similar to other authors.13 Some studies highlight the possibility of self-inoculation or "translocation" of genital site infection.14,21 Our study underscores the need for investigating the anorectal site in women living with HIV/AIDS, regardless of anal intercourse practice.

We found a high rate of anorectal site infection among men (14.0% positive cases, 9.3% for CT and 5.7% for NG), similar to the CT and NG prevalence found in other studies in Brazil (10.0% and 2.5%), USA (7.9% and 6.9%), Netherlands (10.1% and 5.5%), and Russia (7.3% and 2.0%).6,22-24 Only men who referred anal intercourse have CT and NG anal infection. The characteristics of this population are similar to those studied in other countries, with multiple sexual partners, receptive and insertive anal intercourse, higher education/socioeconomic situation. Despite the access to information on STI prevention, the high prevalence indicates a high exposure to NG and CT. These points toward an urgent need for reinforcing preventive measures, such as condom use, education on sexual transmission risk, and prompt access to bacterial and HIV infections post-exposure prophylaxis.

Antiretroviral therapy (ART), HIV viral suppression and improved immune status did not protect against STI infection in urogenital or anal sites in male patients of our study. The available evidence on these factors are controversial: some authors detected more infections in patients with higher TCD4 + cell counts,25 but Cunha et al. did not find such association.22 Some studies have shown an increased transmission of HIV in men or women infected by a bacterial STI, possibly due to the immune activation that increases expression of CCR5 receptors on mucosa and genital viral load.7,26,27 Receptive unprotected anal sex represents risk of HIV transmission of 5-18 times higher on each sexual act.28,29 The sense of protection currently publicized by the use of ART cannot be extended to the STIs on the population of men living with HIV.

This study has limitations: an interview was conducted face to face, leading to some degree of inhibition by the respondents, especially as to sexual practices. The population included in the study attends the service and, therefore, has access to care and guidance. There is no such data on HIV-negative people, or on those who do not attend specialized health centers. PLHA, is a population with increased prevalence of other STIs, and we have to be cautions when extrapolating these findings to the general population. Defining who is the heterosexual population who needs screening for infection in extragenital sites still requires more epidemiological and cost-effectiveness studies.

The "Treat as Prevention" strategy adopted in 2013 by Health Ministry of Brazil30 and in 2015 by the WHO, intends to reduce HIV sexual transmission through increasing virological suppression. The impact of this policy on bacterial STIs transmission, such as syphilis, CT, and NG in PLHA is unknown. The increase of unprotected sex due to the possibility of not occurring sexual transmission of HIV could lead to an increase of these STIs. This may be a limitation to the future success of the "Treat as Prevention" strategy. Training of health professionals, access to early diagnosis and treatment of STIs, educational interventions on sexual practices, risk management, and prevention along with the population, especially PLHA and key populations, are essential measures to end the HIV epidemic, the global goal for 2030, and break bacterial STI chain-of-transmission.

Acknowledgments

The authors are grateful to the Brazilian Department of STD, HIV and Viral Hepatitis, Brazilian Ministry of Health for the financial support (Project BRA/K57).

The authors would also like to thank the Laboratorio Central de Saúde Pública Professor Gonçalo Moniz, LACEN-Bahia for the laboratory support.

The members of the research group Rotina de Saúde Ampliada (RoSA), which contributed to care of the patients, Dr. Patricia M. Almeida, Dra. Sheyla Fernandes, Dr. Karina Adami, Dr. Karen Abbehusen.

References

1 WHO. Global incidence and prevalence of selected curable sexually transmitted infections – 2008; 2012. [ Links ]

2 Miller W, Ford C, Morris M, et al. Prevalence of chlamydial and gonococcal infections among young adults in the United States. JAMA J Am Med Assoc. 2004:801, author reply801-2. [ Links ]

3 Owen BN, Brock PM, Butler AR, et al. Prevalence and frequency of heterosexual anal intercourse among young people: a systematic review and meta-analysis. AIDS Behav. 2015;19:1338-60. [ Links ]

4 Mestecky J, Moldoveanu Z, Smith PD, Hel Z, Alexander RC. Mucosal immunology of the genital and gastrointestinal tracts and HIV-1 infection. J Reprod Immunol. 2009;83:196-200. [ Links ]

5 Stahlman S, Hirz AE, Stirland A, Guerry S, Gorbach PM, Javanbakht M. Contextual factors surrounding anal intercourse in women. Sex Transm Dis. 2015;42:364-8. [ Links ]

6 Koedijk FDH, van Bergen JEAM, Dukers-Muijrers NHTM, van Leeuwen AP, Hoebe CJPA, van der Sande MAB. The value of testing multiple anatomic sites for gonorrhoea and chlamydia in sexually transmitted infection centres in the Netherlands, 2006-2010. Int J STD AIDS. 2012;23:626-31. [ Links ]

7 Johnson L, Lewis D. The effect of genital tract infections on HIV-1 shedding in the genital tract: a systematic review and meta-analysis. Sex Transm Dis. 2008;35:946-59. [ Links ]

8 Kong FYS, Hocking JS. Treatment challenges for urogenital and anorectal Chlamydia trachomatis. BMC Infect Dis. 2015;15:293. [ Links ]

9 Garner AL, Schembri G, Cullen T, Lee V. Should we screen heterosexuals for extra-genital chlamydial and gonococcal infections?. Int J STD AIDS. 2015;26:462-6. [ Links ]

10 Javanbakht M, Gorbach P, Stirland A, et al. Prevalence and correlates of rectal Chlamydia and gonorrhea among female clients at sexually transmitted disease clinics. Sex Transm Dis. 2012;39:917-22. [ Links ]

11 Workowski KA, Bolan GA. Sexually transmitted diseases treatment guidelines. Atlanta, vol. 64; 2015. [ Links ]

12 Lanjouw E, Ossewaarde JM, Stary A, Boag F, van der Meijden WI. 2010 European guideline for the management of Chlamydia trachomatis infections. Int J STD AIDS. 2010;21:729-37. [ Links ]

13 van Liere GAFS, Dirks JAMC, Hoebe CJPA, Wolffs PF, Dukers-Muijrers NHTM. Anorectal Chlamydia trachomatis load is similar in men who have sex with men and women reporting anal sex. PLOS ONE. 2015;10:e0134991. [ Links ]

14 Ladd J, Hsieh Y-H, Barnes M, Quinn N, Jett-Goheen M, Gaydos CA. Female users of internet-based screening for rectal STIs: descriptive statistics and correlates of positivity. Sex Transm Infect. 2014;90:485-90. [ Links ]

15 Travassos AGÁ, Brites C, Netto EM, Fernandes SDA, Rutherford GW, Queiroz CM. Prevalence of sexually transmitted infections among HIV-infected women in Brazil. Braz J Infect Dis. 2012;16:581-5. [ Links ]

16 Jalil E, Pinto V, Benzaken A, et al. Prevalência da infecção por clamídia e gonococo em gestantes de seis cidades brasileiras. Rev Bras Ginecol Obs. 2008;30:614-9. [ Links ]

17 Landes M, Thorne C, Barlow P, et al. Prevalence of sexually transmitted infections in HIV-1 infected pregnant women in Europe. Eur J Epidemiol. 2007;22:925-36. [ Links ]

18 Vogler M, Singh H, Wright R. Complex decisions in managing HIV infection during pregnancy. Curr HIV/AIDS Rep. 2011;8:122-31. [ Links ]

19 Adachi K, Klausner JD, Bristow CC, et al. Chlamydia and Gonorrhea in HIV-infected pregnant women and infant HIV transmission. Sex Transm Dis. 2015;42:554-65. [ Links ]

20 Trebach JD, Chaulk P, Page KR, Tuddenham S, Ghanem KG. Neisseria gonorrhoeae and Chlamydia trachomatis among women reporting extragenital exposures. Sex Transm Dis. 2015;42:233-9. [ Links ]

21 van Liere GAFS, Hoebe CJPA, Wolffs PFG, Dukers-Muijrers NHTM. High co-occurrence of anorectal chlamydia with urogenital chlamydia in women visiting an STI clinic revealed by routine universal testing in an observational study; a recommendation towards a better anorectal chlamydia control in women. BMC Infect Dis. 2014;14:274. [ Links ]

22 Cunha CB, Friedman RK, de Boni RB, et al. Chlamydia trachomatis, Neisseria gonorrhoeae and syphilis among men who have sex with men in Brazil. BMC Public Health. 2015;15:686. [ Links ]

23 Pace CA, Lioznov D, Cheng DM, et al. Sexually transmitted infections among HIV-infected heavy drinkers in St Petersburg, Russia. Int J STD AIDS. 2012;23:853-8. [ Links ]

24 Kent C, Chaw J, Wong W, et al. Prevalence of rectal, urethral, and pharyngeal chlamydia and gonorrhea detected in 2 clinical settings among men who have sex with men: San Francisco, California, 2003. Clin Infect Dis. 2005;41:67-74. [ Links ]

25 Rieg G, Lewis RJ, Miller LG, Witt MD, Guerrero M, Daar ES. Asymptomatic sexually transmitted infections in HIV-infected men who have sex with men: prevalence, incidence, predictors, and screening strategies. AIDS Patient Care STDS. 2008;22:947-54. [ Links ]

26 Jarvis GA, Chang TL. Modulation of HIV transmission by Neisseria gonorrhoeae: molecular and immunological aspects. Curr HIV Res. 2012;29:997-1003. [ Links ]

27 Tanton C, Weiss H, Le Goff J, et al. Correlates of HIV-1 genital shedding in Tanzanian Women. PLoS ONE. 2011;6:10. [ Links ]

28 Baggaley RF, White RG, Boily M-C. HIV transmission risk through anal intercourse: systematic review, meta-analysis and implications for HIV prevention. Int J Epidemiol. 2010;39:1048-63. [ Links ]

29 Boily MC, Baggaley RF, Wang L, et al. Heterosexual risk of HIV-1 infection per sexual act: systematic review and meta-analysis of observational studies. Lancet Infect Dis. 2009;9:118-29. [ Links ]

30 Brasil. Ministério da Saúde. Secretaria de Vigilância em Saúde. Departamento de DST A e HV. Protocolo Clínico e Diretrizes Terapêuticas para manejo da infecção pelo HIV em adultos; 2013. [ Links ]

Received: May 24, 2016; Accepted: September 4, 2016

*Corresponding author. E-mail address: atravassos@uneb.br (A.G. Travassos).

Conflicts of interest

The authors declare no conflicts of interest.

Creative Commons License This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivative License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium provided the original work is properly cited and the work is not changed in any way.